Abstract:Rheumatoid arthritis (RA) patients can be stratified into two subgroups defined by the presence or absence of antibodies against citrullinated circular peptides (anti-CCP) with most of the genetic association found in anti-CCP positive RA. Here we addressed the role of VAV1, previously associated to multiple sclerosis (MS), in the pathogenesis of RA in experimental models and in a genetic association study. Experimental arthritis triggered by pristane or collagen type II was induced in DA rats and in the DA.BN-R25 congenic line that carries a polymorphism in Vav1 . Difference in arthritis severity was observed only after immunization with pristane. In a case–control study, 34 SNPs from VAV1 locus were analyzed by Immunochip genotyping in 11475 RA patients (7573 anti-CCP positive and 3902 negative) and 15,870 controls in six cohorts of European Caucasians. A combination of the previous MS-associated haplotype and two additional SNPs was associated with anti-CCP negative RA (alleles G-G-A-A of rs682626-rs2546133-rs2617822-rs12979659, OR=1.13, P =1.27 × 10 −5 ). The same markers also contributed to activity of RA at baseline with the strongest association in the anti-CCP negative group for the rs682626-rs12979659 G-A haplotype ( β =−0.283, P =0.0048). Our study suggests a role for VAV1 and T-cell signaling in the pathology of anti-CCP-negative RA.

Erratum: VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis

Vav1 Regulates Experimental Autoimmune Arthritis and is Associated with Anti-Ccp Negative Rheumatoid Arthritis

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Erratum: Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Erratum: The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality

Erratum to "Identification of atrial fibrillation-associated microRNAs in left and right atria of rheumatic mitral valve disease patients" [Genes Genet. Syst. (2019) 94, p. 23-34].

Erratum to: Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients

Corrigendum: Immune Phenotyping of Patients With Acute Vogt-Koyanagi-Harada Syndrome Before and After Glucocorticoids Therapy

Corrigendum: Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Erratum: Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease

Erratum: Addendum of Conflict of Interest

Incorrect Institutional Affiliations of Authors in the Article by Jiang Et Al (arthritis Rheumatol, May 2014)

Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335-3346

Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis

Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

Corrigendum to “A Genome-Wide Association Study Identifies a Common Variant Near the GPR22 Gene As a New Locus Involved in Prevalence and Progression of Osteoarthritis” [bone. 44S2 (2009) S224]